BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21350212)

  • 1. Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction.
    Arslan F; Smeets MB; Riem Vis PW; Karper JC; Quax PH; Bongartz LG; Peters JH; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circ Res; 2011 Mar; 108(5):582-92. PubMed ID: 21350212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
    Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
    J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
    Cavasin MA; Tao Z; Menon S; Yang XP
    Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction.
    Vanhoutte D; Schellings MW; Götte M; Swinnen M; Herias V; Wild MK; Vestweber D; Chorianopoulos E; Cortés V; Rigotti A; Stepp MA; Van de Werf F; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2007 Jan; 115(4):475-82. PubMed ID: 17242279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction.
    Yu M; Ishibashi-Ueda H; Ohta-Ogo K; Gabbiani G; Yamagishi M; Hayashi K; Hirota S; Bochaton-Piallat ML; Hao H
    Pathol Int; 2012 Apr; 62(4):246-53. PubMed ID: 22449228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.
    Vilahur G; Juan-Babot O; Peña E; Oñate B; Casaní L; Badimon L
    J Mol Cell Cardiol; 2011 Mar; 50(3):522-33. PubMed ID: 21219908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
    Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
    Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
    Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
    Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
    Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP; Creemers EE
    J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramyocardial injection of tannic acid attenuates postinfarction remodeling: a novel approach to stabilize the breaking extracellular matrix.
    Zhang H; Zhu SJ; Wang D; Wei YJ; Hu SS
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):216-22, 222e1-2. PubMed ID: 19154928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
    J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.